Dr. Gaerolwe Masheto has been appointed BHP Deputy C.E.O. He will resume his duties as Deputy C.E.O on March 1st 2023.

Dr. Gaerolwe Masheto graduated from Ross University School of Medicine in 2007 and completed his medical internship and worked as a Medical Officer at Nyangabgwe Referral Hospital from 2008 to 2011.

Dr. Masheto graduated from Stellenbosch University in 2012 with Post Graduate Diploma in Family Medicine, He is currently enrolled for a Masters (MSc) in Clinical Epidemiology at the London University’s London School of Hygiene and Tropical Medicine.

He joined Botswana Harvard Health Partnership (BHP) Clinical Trials Unit (CTU) in 2011 as a Study Physician and has worked with a team which has successfully conducted International Maternal, Pediatric, Adolescents AIDS Clinical Trials (IMPAACT), AIDS Clinical Trials (ACTG) and HIV Prevention Trials Network (HPTN) clinical trials.

Currently Dr. Masheto is the CTU Coordinator, IMPAACT Network Project Leader/Principal Investigator (PI) and Molepolole Clinical Research Site Leader. Dr. Masheto is also a Co-Investigator for ACTG and HPTN studies. He also runs his own clinical trial within the Motlala Study.